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This experimental study was designed to assess the influence of failure of the 
fight side of the heart or pulmonary hypertension, orboth, on the performance 
of a novel miniaturized left ventricular assist device. In small-sized ogs (n = 
50) ischemic global left ventricular failure was induced and support was 
provided by the HIA-VAD displacement pump (stroke volume 10 or 25 ml) 
installed as a left ventricular assist device. In three groups of animals (n = 10 
each) pulmonary hypertension was created before induction of global left 
ventricular failure. During left ventrieular assist device support emporary 
ischemic failure of the right side of the heart was induced in four groups of 
animals (n = 10 each). In the group subjected to left ventricular failure, 
support with the left ventricular assist device, and right ventricular failure 
during left ventricular assist, left atrial pressure and cardiac index were 
significantly lower than in the group subjected to left ventricular failure and 
left ventricular assist alone (2 _ 6 versus 11 --+ 6 mm Hg and 1.6 _ 0.4 versus 
1.0 -+ 0.4 L/(min/m2), respectively, p < 0.05). In the group subjected to 
pulmonary hypertension, left ventricular failure, and left ventricular support, 
left atrial pressure dropped to values near zero but cardiac index remained 
unaltered as compared with results with the same regimen without pulmonary 
hypertension. However, when right ventricular failure was added (that is, 
pulmonary hypertension, left ventricular failure, left ventricular support, and 
right ventricular failure during support with the left ventricular assist device) 
left atrial pressure dropped to negative values (p < 0.05) and cardiac index 
progressively deteriorated. When, in an additional group of dogs, biventricular 
support was installed in the latter regimen, circulation was initially well 
supported but oxygenation deteriorated in 60% of cases. We conclude that (1) 
adequate right ventricular function was indispensable during support with the 
left ventricular assist device, (2) the combination of pulmonary hypertension 
and right ventricular failure led to the "low left ventricular assist device output 
syndrome," and (3) biventricular mechanical support in the presence of 
pulmonary hypertension may be complicated by the alveolar leakage syn- 
drome. (J Thorac Cardiovasc Surg 1996;112:48403) 
D isplacement pumps that are routinely used for assisted circulation have a common disadvan- 
tage, that is, their large pump chamber size. The 
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Pittsburgh transplant group quite correctly con- 
cluded in its report about pediatric cardiac trans- 
plantation that the lack of an efficient miniaturized 
ventricular assist device is a glaring deficiency in the 
armamentarium of the pediatric cardiac transplant 
surgeon. 1 
Indeed, in children or infants the limitations of 
displacement pumps become obvious when an 
adult-sized pump is used. The pump rate in small 
patients has to decrease greatly; otherwise the filling 
remains incomplete and the rate of thromboembolic 
complications increases dramatically. A solution to 
this problem could be miniaturization of the ventric- 
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ular assist device (VAD). The HIA-VAD, designed 
by the Helmholtz Institute at Aachen, Germany, is a 
displacement pump that can be miniaturized as a 
result of several new features in design and manu- 
facturing. A miniaturized version became available 
to us and was used in this experimental study. 2
Furthermore, in pediatric cardiac operations, the 
problem of low cardiac output syndrome as a result 
of failure of the left, right, or combined left and right 
sides of the heart is often associated with pulmonary 
vasoactive crises, which are more common than in 
adults. 3 It is therefore necessary to study a pediatric 
assist device in this complex pathophysiologic set- 
ting. To study the effect of failure of the right side of 
the heart and pulmonary hypertension on support 
with a left ventricular assist device (LVAD), we 
designed an experimental animal model of severe 
isolated global failure of the left side of the heart. 
Once left ventricular failure (LVF) was induced, an 
LVAD was connected and the circulation was sup- 
ported by the pediatric HIA-VAD system. In a 
second protocol, temporary failure of the right side 
of the heart was induced during LVAD support for 
LVF, and its influence on LVAD function was 
demonstrated. In this way "low LVAD output syn- 
drome" could be studied. In a third protocol, the 
influence of acute pulmonary hypertension on the 
low LVAD output syndrome was assessed. Here, 
acute pulmonary hypertension was created in a 
series of animals, LVF was induced and the circu- 
lation supported by an LVAD. By comparison of the 
results with those obtained in animals without pul- 
monary hypertension, the effect of increased pulmo- 
nary vascular esistance on LVAD output could be 
studied. In ;another protocol, the influence of the 
combination of right ventricular failure (RVF) and 
pulmonary hypertension on LVAD output could be 
studied. Finally, the influence of use of a biventricu- 
lar assist device (BVAD) was demonstrated under 
these circumstances. 
Material and methods 
Experimental preparation. Fifty-five mongrel dogs 
with a body weight of 6 to 18 kg were used in this study. In 
dogs the right coronary artery exclusively supplies the 
right ventricle and only a small part of the anterior wall of 
the right ventricle is perfused by the left anterior descend- 
ing artery. Selective occlusion of left or right coronary 
arteries makes the dog a suitable xperimental species for 
isolated failure of the right or left side of the heart. 
All animals received humane care in compliance with 
the "Guide for the Care and Use of Laboratory Animals" 
formulated by the National Academy of Sciences and 
published by the National Institutes of Health (NIH 
Publication No. 85-23, revised 1985) and with the guide- 
lines of the local ethical committee of the Katholieke 
Universiteit Leuven. 
The dogs were premedicated with Hypnorm analgesic 
(fluanisone 10 mg and fentanyl 0.2 mg/ml) 0.2 ml/kg body 
weight intramuscularly and anesthetized with Nembutal 
anesthetic, 0.2 ml/kg (sodium pcntobarbital 60 mg/ml), 
administered intravenously. The dogs were then intubated 
and the lungs mechanically ventilated with a mixture of 
oxygen, room air, and halothane, 0.2% to 0.4% (until 
instrumentation was completed). Ventilation was adjusted 
to maintain pH and oxygen levels in the satisfactory ange 
as indicated by determination f arterial blood gas values. 
Routine respiration rate was 20 breaths/min, tidal volume 
was 18 to 20 ml/kg body weight, and positive end-expira- 
tory pressure 5 cm H20. Additional doses of Dipodolor 
analgesic (piritramide 10 mg/ml) and Rapifen analgesic 
(fentanyl 0.5 mg/ml) were administered as required to 
maintain anesthesia. 
After induction of anesthesia, catheters were inserted 
into the right femoral artery for obtaining arterial pres- 
sures and blood samples and into the right femoral vein 
for blood transfusions from donor dogs or autologous 
blood retransfusions. In dogs with a hemoglobin content 
of more than 12.5 gm/dl an isovolumic hemodilution was 
done before the thoracotomy toobtain approximately 200 
ml autologous blood. 
A catheter was placed in the left jugular vein for 
measurements of right atrial pressure and for injecting 
ice-cold saline solution for cardiac output measurements. 
Furthermore, a urinary catheter was directly inserted into 
the urinary bladder through a midline minilaparotomy. 
After administration of a 0.2 ml/kg dose of Pavulon 
muscle relaxant (pancuronium 2 mg/ml), a thoracotomy 
was done through the fifth intercostal space. An 8 or 10 
mm Intravascular g aft (for the HIA-VAD 10 ml or 25 ml, 
respectively) was anastomosed nd to side to the descend- 
ing thoracic aorta during partial clamping. A bolus of 
lidocaine (Xylocaine; 1 mg/kg) was injected and a contin- 
uous intravenous infusion started at a rate of 1 mg/kg per 
hour before the pericardium was opened and the heart 
suspended in a pericardial cradle. The coronary arteries 
were dissected (the left anterior descending and the left 
circumflex coronary artery distally from the main stem 
and the right coronary artery) and snares were placed 
around them. According to the protocol, occlusion was 
produced by tightening the snare with a tourniquet and 
reperfusion was recognized as the appearance of reactive 
hyperemia fter removal of the snare. 
During the biventricular pumping an 8 or 10 mm 
vascular graft was anastomosed nd to side to the main 
pulmonary artery during partial clamping. 
After systemic heparinization with a heparin dose of 
100 to 200 IU/kg, depending on activated clotting times, a 
balloon-tipped catheter (Swan-Ganz catheter, Baxter 
Healthcare Corp., Edwards Division, Santa Ana, Calif.) 
was placed in the left pulmonary artery through a stab 
incision in the right ventricular outflow tract. Activated 
clotting time was maintained in the range of 150 to 200 
seconds and measured with a Hemochron 400 instrument 
(International Technidyne Corp., Edison, N.J.). Further, a 
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Fig. 1. Photograph of HIA-VAD pumps. Devices available had stroke volumes of 10 ml, 25 ml, or 60 ml. 
catheter was inserted into the left ventricle through a stab 
incision in the apex for left ventricular pressure record- 
ings. 
The HIA-VAD pump. The HIA-VAD displacement 
pump is a pneumatically driven membrane-type ump 2 
(Fig. 1), of which by different sizes with varying pump 
volumes can be manufactured. Besides the currently avail- 
able 60 ml (adult size) pump, two miniaturized versions 
for pediatric use were produced and were used in our 
studies. These versions have maximal stroke volumes of 10 
ml and 25 ml, respectively. For biventricular support the 
right-sided pumps are available with 10% less stroke 
volume compared with that of left-sided pumps. This 
smaller stroke volume on the right side was achieved by 
decreasing the diameter of the pump membrane. Thus 
different pump outputs can be achieved although the two 
pumps operate at the same pump rates. 
The artificial valves have three leaflets and sinuses, with 
the valves and outlet being conus shaped. This structure 
was based on findings obtained from in vitro flow visual- 
ization techniques and finite element method stress anal- 
ysis, which showed the conical design to have superior 
performance specially in the open position. 2 This new 
valve design allows a reduction of driving pressures and 
vacuum, improves the filling behavior, and avoids clot 
formation as demonstrated during in vivo testing. 2 With 
use of a new manufacturing technique, the valves are 
made of polyurethane with favorable biocompatibility 
features. Because of the unique molding process, a pump 
is produced that is seamless and has optimal membrane 
performance even in the smallest available size of 10 ml 
pumping volume. A special gluing technique provides a 
smooth transition between the parts, and silicone oil used 
as a lubricant between the pump membranes leads to a 
completely transparent blood pump that can be easily 
deaired. All surfaces in contact with blood were made of 
biocompatible polyurethane. 
A new driving system manufactured by Medos (Mediz- 
intechnik GmbH, Stolberg, Germany) was used. This 
system uses compressed air and applies vacuum and 
positive pressure. Four different parameters can be al- 
tered and adjusted according to the hemodynamic needs: 
systolic driving pressure, diastolic vacuum, duration of 
systole, and pump rate. This unit can provide univentricu- 
lar and biventricular support for all three pump sizes. 
The 10 ml HIA-VAD pump was used in dogs with a 
body weight between 6 and 10 kg (n -- 25), and the 25 ml 
HIA-VAD pump was used in dogs with a body weight 
between 10 and 19 kg (n = 25). In the control group 
without HIA-VAD pump support (n -- 5) the body weight 
was 12-+ lkg .  
The HIA-VAD pump was connected to the inflow 
cannula (Polystan Bent Hard No. 28 [Polystan, Copenha- 
gen, Denmark[ in case of HIA-VAD 10 ml pump or No. 
36 in case of H1A-VAD 25 ml pump), which was intro- 
duced into the left auricular appendage and secured with 
a purse-string suture, and to the outflow cannula (Re- 
search Medical FEM FLEX No. 20 or No. 24 [Research 
Industries Corp., Midvale, Utah], respectively), which was 
inserted into the graft on the descending aorta. A catheter 
was inserted into the left atrium. 
Depending on the protocol the right ventricular assist 
device (RVAD) was connected to the inflow cannula 
(Polystan Bent Hard No. 28 or No. 36), which was 
positioned in the right atrium after being introduced into 
the right auricular appendage through a purse-string 
suture, and to the outflow cannula (Research Medical 
FEM FLEX No. 20 or No. 24), which was inserted into the 
graft in the pulmonary artery. If the animals could be 
weaned from the VADs the cannulas were removed. After 
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the experimen~ the animals were killed by an intravenous 
injection of pentobarbital nd potassium chloride. 
Experimental protocols. The canine coronary system is 
strongly collateralized. 4 Therefore the LVF model re- 
quired several subsequent coronary occlusions. 
Global LVF was induced in all dogs. This was done by 
sequential occlusions of the left anterior descending ar- 
tery (20 minutes) and the circumflex artery (45 minutes) 
followed by reperfusion. Circumflex occlusion was done 
after 5 minutes of reperfusion ofthe left anterior descend- 
ing artery. This sequence induced severe global left ven- 
tricular stunning (LVF). LVAD support was started 
shortly after circumflex occlusion, that is, when severe 
LVF occurred. According to the protocol, RVF was 
induced after LVAD support was begun in the presence of 
LVF. RVF was induced by 45 minutes of occlusion of the 
right coronary artery followed by reperfusion. 
Acute pulmonary hypertension was produced by injec- 
tion of 100 /xm glass beads into the pulmonary circula- 
tion s, 6 before LVF was induced. 
The following experimental protocols were designed. 
Groups without pulmonary hypertension. Three groups 
had no pulmonary hypertension: (1) LVF with no me- 
chanical support (group I, n = 5); (2) LVF plus LVAD 
support (group II, n = 10); and (3) LVF plus LVAD 
support plus RVF during LVAD support (group III, n = 
10). 
Groups with pulmonary hypertension. Three further 
groups with pulmonary hypertension were formed: (1) 
LVF plus LVAD support (group IV, n = 10); (2) LVF 
plus LVAD support plus RVF during LVAD support 
(group V, n = 10); and (3) LVF plus LVAD support plus 
RVF and RVAD support (group VI, n = 10). 
Systolic, diastolic, and mean systemic pressures and 
pulmonary arterial pressure (PAP), left atrial pressure 
(LAP), right atrial pressure (RAP), maximum and mini- 
mum rate of pressure rise, cardiac output, mixed venous 
blood gas values, and urinary production were measured 
at baseline before ischemia; after 10 and 19 minutes of 
occlusion of the left anterior descending artery; after 5 
minutes of reperfusion; after 10, 20, 30, and 40 minutes of 
circumflex occlusion; after 5, 10, 15, 30, 45, and 60 minutes 
of reperfusion; and then every 30 minutes until the end of 
the experiment. Blood samples for lactate determination 
were taken at baseline, and sampling was restarted at 
reperfusion after circumflex occlusion at the intervals 
described. 
Statistics..All data are expressed as mean values plus 
or minus standard eviations. The differences within one 
experiment and the differences between individuals and 
groups were computed with a two-factor (time and treat- 
ment) analysis of variance and with repeated measures on 
one factor (time). If the F value was significant, he 
differences between groups were evaluated with Fisher's 
test as a post hoc test, considering a probability value of 
less than 5% (p < 0.05) to be significant. 
The significance of changes from baseline values was 
determined by the Bonferroni-Dunn test. 
For the computations we used the commercially avail- 
able software programs StatView 4.0 (Abacus Concepts, 
Inc., Berkeley, Calif.) and SuperANOVA 1.11 (Abacus 
Concepts) on a Macintosh Powerbook 180 (Apple Com- 
puter, Inc., Cupertino, Calif.). 
Results 
Validation of the experimental model. In the 
control group (LVF without LVAD) irreversible 
cardiogenic shock developed uring global left ven- 
tricular dysfunction i  all animals. After induction of 
anterior wall akinesia by occlusion and reperfusion 
of the left anterior descending artery, cardiac index 
dropped from 3.8 +_ 1 to 2.6 _+ 1.4 L/(min/m 2) (p < 
0.05) and LAP increased from 5 + 4 mm Hg to 13 _+ 
10 mm Hg (p < 0.05). Also, mean aortic pressure 
decreased from 84 + 21 to 65 _+ 20 mm Hg, mean 
pulmonary pressure increased from 12 +_ 3 to 19 -+ 
9 mm Hg, and RAP also increased from 4 _+ 2 to 8 +- 
6 mm Hg. These changes, however, did not reach 
statistical significance (p > 0.05). 
This part of the experimental protocol was similar 
in all further groups and the data obtained in the 
other groups did not differ significantly from those 
in the control group (  > 0.05). Subsequent occlu- 
sion and reperfusion of the circumflex artery, that is, 
after reperfusion of the left anterior descending 
artery, induced global left ventricular hypocontrac- 
tility. Ventricular fibrillation necessitating frequent 
defibrillation attempts and cardiac massage also 
occurred during this phase. Progressively, irrevers- 
ible low cardiac output developed and four of five 
dogs died within the first hour of global LVF. One 
dog initially recovered but died 2 hours after induc- 
tion of global LVF as a result of low cardiac output 
and intractable ventricular fibrillation. 
Effect of RVF on LVAD support. When LVAD 
support was started during global LVF (group II), 
hemodynamics stabilized and all animals could be 
weaned from LVAD support after 90 minutes of 
support. During the last 45 minutes of LVAD 
support, it should be noted, all coronary arteries 
were reopened. During this period the LVAD com- 
pensated for post&chemic global left ventricular 
dysfunction as observed in group I and allowed 
recovery from global stunning. All animals survived 
the observation period. 
During LVAD support, LAP progressively 
dropped from 15 + 7 mm Hg to 8 -+ 1 mm Hg at the 
end of support (p < 0.05; Fig. 2, lower left panel). 
Mean aortic pressure and cardiac index recovered to 
prepump levels at the end of support (Fig. 3, left 
panels, triangles). Mean PAP and RAP decreased 
during LVAD support to baseline values (Fig. 2, 
upper left panel). 
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Fig. 2. Hemodynamics before, during (shaded area), and after LVAD support. Arrows indicate induction 
of failure of left side of heart (LHF) or failure of right side of heart (RHF). mPAP, Mean PAP. 
On induction of transient RVF during LVAD 
(group III), PAP dropped significantly, RAP in- 
creased significantly (p < 0.05), and both pressures 
equalized (Fig. 2, upper right panel). At the same 
time, LAP decreased to much lower values than 
during the same interval in group II (LHF plus 
LVAD without RHF): 11 + 6 mm Hg in group II 
versus 2 _+ 6 mm Hg in group III (p < 0.05; Fig. 2, 
lower right panel). Simultaneously, the cardiac index 
dropped to a significantly lower value than in group 
II (1.6 _+ 0.4 L/[min/m 2] in group II versus 1 _+ 0.4 
L/[min/m 2] in group III; p < 0.05) (Fig. 3, lower left 
panel). 
After reperfusion of the right ventricle during 
LVAD support, right ventricular function recov- 
ered, PAP increased, RAP decreased, and LAP and 
cardiac index increased to levels comparable to 
those in group II (p > 0.05; Fig. 2, right panels). 
Also, hemodynamics after weaning did not differ 
significantly between the groups (p > 0.05). The 
data are presented in Figs. 2 and 3. 
Effect of pulmonary hypertension on LVAD sup- 
port. The injection of glass beads resulted in a 
significant increase in pulmonary resistance and 
PAP. Pulmonary resistance was 613 _ 222 mm 
Hg • min • m2/L and 538 + 160 mm Hg • min • m2/L 
in groups IV and V, respectively, versus 138 ___ 45 
mm Hg.min .m2/L  and 164 ___ 107 mm 
Hg.  rain. m2/L in groups II and III, respectively 
(p < 0.05). Mean PAP was 27.6 _+ 4 mm Hg and 
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Fig. 3. Hemodynamics before, during (shaded area), and after LVAD support. In groups III, IV, and VI 
RVF was induced after LVF, asindicated in Fig. 2, Jqght panels. In group VI biventricular support was
performed. APm, Mean aortic pressure; LHF, failure of left side of heart. 
26.9 +__ 3.5 mm Hg in groups IV and V, respectively, 
versus 13,8 + 2.2 mm Hg and 12.4 + 2.9 mm Hg in 
groups II and III, respectively (p < 0.05). 
When LVF was induced in groups IV and V, 
hemodynamie changes occurred comparable to 
those in groups II and III, with the difference that 
the already increased PAP decreased slightly but not 
significantly. 
Installation of LVAD support in group IV (Fig. 4, 
lower left panel) resulted in an immediate decrease 
of LAP to zero pressure during the entire LVAD 
pumping period. This clearly contrasted with the 
corresponding data in group II (p < 0.01). PAP 
dropped slightly with the onset of LVAD support 
but remained substantially higher than RAP 
throughout the time of pump support (Fig. 4, upper 
leflpanel). Mean arterial pressure and cardiac index 
during LVAD support was somewhat lower than in 
group II although the difference did not reach 
significance (p > 0.05; Fig. 3, closed triangles, right 
panels). 
After weaning from the LVAD, cardiac index and 
arterial pressure slowly deteriorated, and 3 of the 10 
animals died as a result of low cardiac output. 
When transient RVF was induced uring LVAD 
support in animals having pulmonary hypertension 
(group V), PAP dropped ramatically to 8 mm Hg 
and equalized with RAP (Fig. 4, upper right panel). 
LAP dropped immediately to negative values (p < 
0.05) (Fig. 4, lower right panel). Further, arterial 
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Fig. 4. Hemodynamics before, during (shaded area), and after LVAD support. Abbreviations re same as 
used in Fig. 2. 
pressure and cardiac index dropped sharply to zero. 
Reperfusion of the right ventricle did not result in 
any recovery of LVAD output and cardiac index 
dropped toward zero (Fig. 3, closed circles, right 
panel). Thus irreversible low LVAD output syn- 
drome developed and all animals died during 
LVAD support. 
Biventrieular HIA-VAD pump support. In group 
VI animals, pulmonary hypertension was also in- 
duced whereby mean PAP increased to 27.9 -+ 6 mm 
Hg. LVF was induced as in all previous protocols 
and hemodynamics hanged initially in a way similar 
to those in protocols IV and V. Then RVF was 
induced and BVAD support was started immedi- 
ately (Fig. 5) This resulted in a small drop in PAP 
and RAP but not in an equalization of PAP and 
RAP as seen in group V. Pulmonary pressure re-
mained high and RAP decreased uring BVAD 
support (Fig. 5, upper panel), LAP dropped to zero 
(Fig. 5, lower panel) and cardiac index was table at 
about 1.5 L/(min/m2). In 3 of 10 animals, however, 
oxygenation deteriorated and fluid exudated into 
the trachea. In these animals a low BVAD output 
syndrome occurred and the animals died. In the 
remaining seven animals, LAP dropped to zero, but 
cardiac index remained stable (Fig. 3, open squares, 
lower right panel). In these animals mixed venous 
oxygenation ranged between 45% and 75%. After 
weaning from BVAD support, low cardiac output 
developed in three further animals and they died 
during the observation period. Thus 4 of 10 animals 
survived the entire observation period. 
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Discussion 
The pulmonary circuit represents only about 10% 
of the total peripheral resistance against which the 
heart performs, an additional load that is exactly 
bearable by the left ventricle alone] In clinical cases 
of excessive right ventricular infarction, pressures 
recorded in the pulmonary artery and in the right 
atrium equalized, indicating that the right ventricle 
did not serve as a pump any more. Under these 
conditions, the right ventricle was considered to be 
dispensable, a because the intact left side of the heart 
alone could support he circulation. 
Our results show, however, that this concept of 
the dispensable right ventricle is not valid in case of 
left ventricular mechanical ssistance. Most proba- 
bly the reason for this is related to the importance of
the activity of the interventricular septum. Indeed, 
malfunction of the interventricular septum has a 
severe impact on right ventricular function, 9'10 and 
it might well be that the right ventricle, defined as 
the right ventricular free wall, may be dispensable 
provided the interventricular septum is normocon- 
tractile and the pulmonary resistance remains nor- 
mal. In a situation of global eft ventricular dysfunc- 
tion, although the ventricle is supported and 
unloaded by an LVAD system, the septal wall 
motion is lacking. Therefore right ventricular isch- 
emia and dysfunction immediately ead to a "low 
LVAD output syndrome." 
It has been previously reported in an experimen- 
tal model of acute pulmonary hypertension that the 
increase in mean pulmonary pressure was associated 
with a decrease instroke volume and cardiac output, 
even under conditions of normal right ventricular 
function. 11 We also observed this phenomenon after 
induction of pulmonary hypertension during base- 
line conditions in our experiments: cardiac output 
was lower than in the groups without pulmonary 
hypertension. Furthermore, a study on increased 
right ventricular afterload showed that under nor- 
mal conditions the right ventricle operates as a flow 
pump and has reserves in terms of increasing its 
stroke work. 9 In this mode if the maximal stroke 
work occurred at  mean PAP of 20 to 30 mm Hg, 
the right ventricle failed as a pump. Decreasing the 
cardiac output decreases the oxygen supply, and this 
will further educe organ function. Right ventricular 
efficiency will decline and, at even lower pulmonary 
pressures, pump flow will decrease. The mean PAP 
at baseline conditions in our experiments was just 
below 30 mm Hg (27.2 _~ 4.2 mm Hg), which forced 
the right ventricle toperform work with the maximal 
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Fig. 5. Hemodynamics before, during (shaded area), nd 
after BVHD. Abbreviations are s me as use d in Fig. 2. 
possible fficiency, provided sufficient oxygen supply 
was available. 
The model of acute pulmonary hypertension pro- 
duced by glass beads is a well-established model, s' 6 
Glass bead injections produce a situation in the 
pulmonary microvasculature that is comparable with 
that of acute respiratory distress syndrome. The 
amount of pulmonary edema caused by damage of 
endothelial membranes after glass bead injections i  
minimal, provided astable hemodynamic situation is
maintained, the right ventricle does not fail, and the 
gas exchange in the lungs does not deteriorate. 
Other groups have combined glass bead injections 
with injections of oleic acid to reach a pulmonary 
situation that mimics acute respiratory distress yn- 
drome even better and to study gaseous exchange 
and changes in lung compliance. 
4 9 2 Waldenberger et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
August 1996 
The clinical application of this model is limited to 
specific situations. Often pulmonary hypertension is 
reversible and disappears after commencement of 
left ventricular support. However, in two situations 
this model of pulmonary hypertension is applicable: 
(1) fixed pulmonary hypertension in congenital 
pathologic onditions and (2) pulmonary hyperten- 
sion as a result of pulmonary edema caused by 
capillary leak syndrome, which occurs after massive 
blood transfusion, prolonged bypass time, or acute 
respiratory distress yndrome. 
From our experimental work it is evident hat a 
combination of LVAD support and pulmonary hy- 
pertension leads to a decrease in pulmonary blood 
flow and inflow into the left side of the heart to such 
an extent that it becomes life threatening. The 
combination of RVF and pulmonary hypertension 
was not compatible with survival. As already men- 
tioned, right atrial and pulmonary pressures leveled 
off during right coronary artery ischemia nd LVAD 
support. After a few minutes of right ventricular 
ischemia, sufficient inflow into the left side of the 
heart ceased and the peripheral circulation could 
not be maintained, regardless of the powerful eft 
ventricular mechanical circulatory support. Even 
negative left atrial pressures because of maximal 
vacuum on the left pump did not force enough 
blood through the lungs. 
To overcome this problem of RVF associated 
with pulmonary hypertension, we added an RVAD 
to the LVAD and performed biventricular mechan- 
ical assisted circulation and mechanical unloading. 
In the clinical setting the results of such a BVAD 
support in terms of survival are rather disappointing 
and hardly reach 40%. The outcome depends largely 
on patient reatment after biventricular failure has 
been diagnosed. In patients with biventricular fail- 
ure who require a BVAD for survival, this decision 
has to be made quickly. 12 However, caution is 
needed in patients with capillary leak syndrome 
because the acutely increased pulmonary blood flow 
provided by the RVAD can produce overwhelming 
pulmonary edema) 3 A suggested way to prevent this 
is to restrict volume loading in those patients be- 
cause of the risk of a capillary leak syndrome or to 
perform hemofiltration. However, these events 
seem to precede a lethal outcome. 14 In our experi- 
mental series we found a survival rate of 40%, 
identical to that in the clinical reports. In one dog 
acute alveolar leakage syndrome developed and 
acute pulmonary edema led to instant death. In two 
other dogs progressive dema occurred and the 
leakage into the tissues proceeded more slowly. The 
dogs subsequently died after 2 hours. 
The development of pulmonary edema in the 
presence of a very low left atrial pressure is difficult 
to explain. It might be because acute pulmonary 
hypertension i duces capillary leakage and an in- 
crease in extravascular lung water along with isch- 
emia and subsequent release of neurohumoral fac- 
tors. 15 The critical closing pressure increases 
because of progressive arteriolar tension caused by 
increased extravascnlar water and humoral fac- 
tors, 16 and hypoxemia dds to the impairment. 17
The critical closing pressure in the lung exceeds 
LAP and becomes the critical outflow pressure of 
the right ventricle. 18 In the group with right coro- 
nary artery occlusion and pulmonary hypertension, 
pulmonary pressures fell under the critical closing 
pressure and the flow through the lung ceased. 
However, if RVAD support produced pressures 
higher than the closing pressures, the flow through 
the lungs was maintained. Because of the endothe- 
lial injury and the overdistention of the pulmonary 
vessels, high RVAD outflow pressures can induce 
acute or progressive pulmonary edema as a lethal 
consequence. 
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